UBS Group’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.52M Buy
76,223
+57,651
+310% +$1.15M ﹤0.01% 4047
2025
Q1
$314K Sell
18,572
-33,988
-65% -$574K ﹤0.01% 4993
2024
Q4
$971K Buy
52,560
+42,648
+430% +$788K ﹤0.01% 4229
2024
Q3
$215K Sell
9,912
-10,466
-51% -$227K ﹤0.01% 4645
2024
Q2
$400K Sell
20,378
-6,752
-25% -$132K ﹤0.01% 4088
2024
Q1
$589K Sell
27,130
-3,737
-12% -$81.1K ﹤0.01% 3974
2023
Q4
$892K Buy
30,867
+15,028
+95% +$434K ﹤0.01% 3527
2023
Q3
$424K Buy
15,839
+2,448
+18% +$65.5K ﹤0.01% 3719
2023
Q2
$496K Buy
13,391
+2,552
+24% +$94.5K ﹤0.01% 3829
2023
Q1
$338K Sell
10,839
-1,623
-13% -$50.7K ﹤0.01% 3972
2022
Q4
$371K Sell
12,462
-709
-5% -$21.1K ﹤0.01% 3921
2022
Q3
$503K Sell
13,171
-7,859
-37% -$300K ﹤0.01% 3368
2022
Q2
$1.15M Sell
21,030
-10,507
-33% -$573K ﹤0.01% 2787
2022
Q1
$1.97M Sell
31,537
-14,978
-32% -$935K ﹤0.01% 2664
2021
Q4
$4.68M Buy
46,515
+5,592
+14% +$563K ﹤0.01% 2150
2021
Q3
$3.68M Buy
40,923
+11,880
+41% +$1.07M ﹤0.01% 2270
2021
Q2
$2.68M Buy
29,043
+632
+2% +$58.3K ﹤0.01% 2494
2021
Q1
$2.75M Buy
28,411
+961
+4% +$92.8K ﹤0.01% 2479
2020
Q4
$1.43M Buy
27,450
+26,830
+4,327% +$1.4M ﹤0.01% 2893
2020
Q3
$25K Sell
620
-3,381
-85% -$136K ﹤0.01% 5263
2020
Q2
$64K Buy
4,001
+3,188
+392% +$51K ﹤0.01% 4833
2020
Q1
$9K Sell
813
-650
-44% -$7.2K ﹤0.01% 6073
2019
Q4
$19K Buy
1,463
+138
+10% +$1.79K ﹤0.01% 5830
2019
Q3
$14K Buy
+1,325
New +$14K ﹤0.01% 5978
2018
Q4
Sell
-1,189
Closed -$5K 7109
2018
Q3
$5K Sell
1,189
-630
-35% -$2.65K ﹤0.01% 6560
2018
Q2
$8K Buy
1,819
+12
+0.7% +$53 ﹤0.01% 6330
2018
Q1
$7K Buy
1,807
+1,407
+352% +$5.45K ﹤0.01% 6181
2017
Q4
$2K Sell
400
-1,345
-77% -$6.73K ﹤0.01% 6625
2017
Q3
$8K Buy
1,745
+1,703
+4,055% +$7.81K ﹤0.01% 6073
2017
Q2
$0 Sell
42
-353
-89% ﹤0.01% 6735
2017
Q1
$4K Sell
395
-741
-65% -$7.5K ﹤0.01% 6134
2016
Q4
$13K Buy
+1,136
New +$13K ﹤0.01% 5803